HRP20080452T3 - Farmaceutski pripravak koji se raspada u ustima isadrži risperidon - Google Patents

Farmaceutski pripravak koji se raspada u ustima isadrži risperidon

Info

Publication number
HRP20080452T3
HRP20080452T3 HR20080452T HRP20080452T HRP20080452T3 HR P20080452 T3 HRP20080452 T3 HR P20080452T3 HR 20080452 T HR20080452 T HR 20080452T HR P20080452 T HRP20080452 T HR P20080452T HR P20080452 T3 HRP20080452 T3 HR P20080452T3
Authority
HR
Croatia
Prior art keywords
risperidon
outs
pharmaceutical preparation
risperidone
polymethacrylate
Prior art date
Application number
HR20080452T
Other languages
English (en)
Croatian (hr)
Inventor
Kroselj Vesna
Rajer Tadeja
Rangus Marija
Gustin Jozica
Original Assignee
Krka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka filed Critical Krka
Publication of HRP20080452T3 publication Critical patent/HRP20080452T3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HR20080452T 2004-06-15 2005-06-14 Farmaceutski pripravak koji se raspada u ustima isadrži risperidon HRP20080452T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004028940A DE102004028940A1 (de) 2004-06-15 2004-06-15 Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält
PCT/EP2005/006375 WO2005123084A1 (en) 2004-06-15 2005-06-14 Orally disintegrating pharmaceutical composition comprising risperidone

Publications (1)

Publication Number Publication Date
HRP20080452T3 true HRP20080452T3 (hr) 2008-10-31

Family

ID=34971693

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080452T HRP20080452T3 (hr) 2004-06-15 2005-06-14 Farmaceutski pripravak koji se raspada u ustima isadrži risperidon

Country Status (13)

Country Link
EP (1) EP1768673B1 (sr)
AT (1) ATE402706T1 (sr)
DE (2) DE102004028940A1 (sr)
EA (1) EA010178B1 (sr)
ES (1) ES2311230T3 (sr)
HR (1) HRP20080452T3 (sr)
NO (1) NO20070187L (sr)
PL (1) PL1768673T3 (sr)
PT (1) PT1768673E (sr)
RS (1) RS50609B (sr)
SI (1) SI1768673T1 (sr)
UA (1) UA87692C2 (sr)
WO (1) WO2005123084A1 (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
JP5275815B2 (ja) * 2006-12-26 2013-08-28 塩野義製薬株式会社 リスペリドンを含有する口腔内崩壊錠剤および苦味抑制製剤
CN101269014B (zh) * 2007-03-21 2012-11-14 江苏万特制药有限公司 一种利培酮的口腔崩解片及其制备方法
WO2008152729A1 (ja) * 2007-06-15 2008-12-18 Teikokumedix Co., Ltd. リスペリドンを含むゼリー状の医薬組成物
CN101485636B (zh) * 2008-01-14 2010-12-22 齐鲁制药有限公司 利培酮口腔崩解片及其制备方法
WO2013095314A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Pharmaceutical formulations comprising risperidone
WO2013100876A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Risperidone formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69710460T2 (de) * 1996-06-17 2002-10-02 Janssen Pharmaceutica N.V., Beerse Bikonvexe, rasch desintegrierende verabreichungsformen
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
JP4019374B2 (ja) * 2001-07-27 2007-12-12 アステラス製薬株式会社 口腔内速崩壊錠用徐放性微粒子含有組成物およびその製造法
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
JP4739217B2 (ja) * 2003-05-07 2011-08-03 サムヤン コーポレイション 速く溶ける錠剤を製造するための高可塑性顆粒
WO2005120463A1 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Rapidly disintegrating tablets of risperidone

Also Published As

Publication number Publication date
ES2311230T3 (es) 2009-02-01
EA010178B1 (ru) 2008-06-30
PL1768673T3 (pl) 2009-01-30
UA87692C2 (ru) 2009-08-10
DE602005008607D1 (de) 2008-09-11
EP1768673A1 (en) 2007-04-04
WO2005123084A1 (en) 2005-12-29
NO20070187L (no) 2007-03-02
PT1768673E (pt) 2008-10-21
SI1768673T1 (sl) 2008-12-31
EA200700023A1 (ru) 2007-06-29
EP1768673B1 (en) 2008-07-30
DE102004028940A1 (de) 2006-01-12
ATE402706T1 (de) 2008-08-15
RS50609B (sr) 2010-06-30

Similar Documents

Publication Publication Date Title
IS2580B (is) Platínuafleiða lyfjasamsetningar
ATE392863T1 (de) Streifen zur abgabe eines mundpflegewirkstoffes
ITTO20010005A1 (it) Formulazione farmaceutica.
EE05081B1 (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, 3-aminoasetidiini derivaadid ja nende valmistamise meetodid
KR20050009999A (ko) 약제학적 제제
NO20033384L (no) Farmasoytisk formulering
DE60307677D1 (de) Dispergierbare pharmazeutische zusammensetzungen
HN2003000054A (es) Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo (cetpi), a procedimientos de uso y a procedimientos de preparacion de las mismas.
EE200300581A (et) Karboksamiid-asendatud fenüüluurea derivaadid ja nende kasutamine, ravim ja selle valmistamismeetod
NO20033785D0 (no) Farmasöytisk formulering
NO20040356L (no) Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling.
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
NO20035627D0 (no) Farmasöytisk formulering
EE05385B1 (et) LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon
DK1643976T3 (da) Farmaceutisk formulering omfattende levothyroxinnatrium
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
HRP20080452T3 (hr) Farmaceutski pripravak koji se raspada u ustima isadrži risperidon
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
EP1911761A4 (en) WATER-SOLUBLE ARTEMISININE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
EE05384B1 (et) LaiaspektrilisedÁ2-(asendatudÁamino)bensoksasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁkasutamine,ÁfarmatseutilineÁkompositsioonÁjaÁmeetodÁretroviiruseÁreplikatsiooniÁinhibeerimiseks
NO20042890L (no) Farmasoytiske preparater og fremgangsmate for fremstilling derav
NO20043007L (no) Farmasoytisk suspensjon for oral administrering